Fig 1 - حسب Samuel Hylander (331771)

الموضوعات:

Fig 5 - حسب Samuel Hylander (331771)

الموضوعات:

Fig 4 - حسب Samuel Hylander (331771)

الموضوعات:

Fig 2 - حسب Samuel Hylander (331771)

الموضوعات:

Total thiamin content (log; nmol gC^-1) in phytoplankton, zooplankton, planktivorous fish, piscivorous fish and omnivorous fish (drawings modified from [52]). حسب Samuel Hylander (331771)

الموضوعات:

Fig 3 - حسب Samuel Hylander (331771)

الموضوعات:

Fig 6 - حسب Samuel Hylander (331771)

الموضوعات:

A summary of the included study characteristics. حسب Zahra Tajik (20752452)

"…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …"

Lecturers by gender. حسب Ignacio García-Espona (21395335)

الموضوعات:

Thematic cloud for posters [2013-23]. حسب Ignacio García-Espona (21395335)

الموضوعات:

Posters by gender. حسب Ignacio García-Espona (21395335)

الموضوعات:

Thematic clouds for lectures. حسب Ignacio García-Espona (21395335)

الموضوعات:

Sample Data. حسب Ignacio García-Espona (21395335)

الموضوعات:

Overview of the six original ACTIV-3/TICO trials. حسب Elizabeth S. Munroe (21568166)

Inhibition of NEAT1 decreased the miR-204-5p expression and increased Six1 expression. حسب Lei Li (29537)

"…<p>(A) NEAT1 expression following siRNA transfection in BEAS-2B cells; (B-D) The expression of NEAT1, miR-204-5p, and Six1 after decreasing NEAT1 expression. * p <0.05, *** p < 0.001, and **** p <0.0001.…"

A path model of six-factor self-compassion. حسب Eriko Takahashi (22608061)

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. حسب Gillian P. McHugo (8965919)

Sleep deprivation increased inflammatory cytokines and decreased corticosterone in the blood. حسب Weiran Shan (16969688)

List of Included studies. حسب Zahra Tajik (20752452)

"…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …"

The search strategy in three databases. حسب Zahra Tajik (20752452)

"…The results show that one month after the NSPT, there was no significant difference in the mean visfatin level of GCF (SMD: -3.91, 95%CI: -9.83, 2.01, p = 0.195, I-square, 96.6%, random effect model, n = 2) and serum (SMD: -0.33, 95%CI: -0.98, 0.33, p = 0.332, fixed effect model, n = 1), but 2, 3 and 6 months after NSPT, the mean visfatin level of GCF and serum decreased significantly. There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …"